Comparison of anticancer activity between lactoferrin nanoliposome and lactoferrin in Caco-2 cells in vitro

Food and Chemical Toxicology

Volumn 59, Issue , 2013, Pages 72-77

  Ma, Jieqing ^a   Guan, Rongfa ^a   Shen, Haitao ^b   Lu, Fei ^c   Xiao, Chaogeng ^d   Liu, Mingqi ^a   Kang, Tianshu ^a  

^a CHINA JILIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^d INSTITUTE OF PLANT PROTECTION AND MICROBIOLOGY   (China)

Author keywords

Caco 2; Cell viability; Lactoferrin nanoliposomes; MTT

Indexed keywords

LACTATE DEHYDROGENASE; LACTOFERRIN; LIPOSOME; MALONALDEHYDE; NANOLIPOSOME; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN CACO 2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; MITOCHONDRION;

CACO-2; CELL VIABILITY; LACTOFERRIN NANOLIPOSOMES; MTT;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CACO-2 CELLS; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG STABILITY; ENZYME STABILITY; HUMANS; KINETICS; LACTOFERRIN; LIPID PEROXIDATION; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; NANOSPHERES; NEOPLASM PROTEINS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; RECEPTORS, CHOLECYSTOKININ;

EID: 84879442549     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.05.038     Document Type: Article

References (40)

1. Baker E.N., Baker H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci. 2005, 62:2531-2539.
2. Bezault J., Bhimani R., Wiprovnick J., Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res. 1994, 54:2310-2312.
3. Burrow H., Kanwar R.K., Kanwar J.R. Antioxidant enzyme activities of iron-saturated bovine lactoferrin (Fe-bLf) in human gut epithelial cells under oxidative stress. Med. Chem. 2011, 7:224-230.
4. Burrow H., Kanwar R.K., Mahidhara G., Kanwar J.R. Effect of selenium-saturated bovine lactoferrin (Se-bLF) on antioxidant enzyme activities in human gut epithelial cells under oxidative stress. Anticancer Agents Med. Chem. 2011, 11:762-771.
5. Campbell T., Skilton R.A., Coombes R.C., Shousha S., Graham M.D., Luqmani Y.A. Isolation of a lactoferrin cdna clone and its expression in human breast cancer. Br. J. Cancer 1992, 65:19-26.
6. Carlisle R., Seymour L.W., Coussios C.C. Targeting of liposomes via PSGL1 for enhanced tumor accumulation. Pharm. Res. 2013, 30:352-361.
7. Cuddihy, R.G., Kanapilly, G.M., Raabe, O.G., 1969. Relationship between particle size and respiratory deposition of 140la-labeled aerosols in the beagle dog. Lf-41. Fission Prod Inhal Proj.82-87.
8. Damiens E., Mazurier J., el Yazidi I., Masson M., Duthille I., Spik G., Boilly-Marer Y. Effects of human lactoferrin on Nk cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim. Biophys. Acta 1998, 1402:277-287.
9. Ding B.M., Zhang X.M., Hayat K., Xia S.Q., Jia C.S., Xie M.H., Liu C.M. Preparation, characterization and the stability of ferrous glycinate nanoliposomes. J. Food Eng. 2011, 102:202-208.
10. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51:691-743.
11. Duarte D.C., Nicolau A., Teixeira J.A., Rodrigues L.R. The effect of bovine milk lactoferrin on human breast cancer cell lines. J. Dairy Sci. 2011, 94:66-76.
12. Felnerova D., Viret J.F., Gluck R., Moser C. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr. Opin. Biotechnol. 2004, 15:518-529.
13. Gao D., Liu J., Wei H.B., Li H.F., Guo G.S., Lin J.M. Microfluidic approach for anticancer drug analysis based on hydrogel encapsulated tumor cells. Anal. Chim. Acta 2010, 665:7-14.
14. García-Montoya I.A., Cendón T.S., Arévalo-Gallegos S., Rascón-Cruz Q. Lactoferrin a multiple bioactive protein: an overview. Biochim. Biophys. Acta 2012, 1820:226-236.
15. González-Chávez S.A., Arévalo-Gallegos S., Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents 2009, 33(301):e301-e308.
16. Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 1995, 13:527-537.
17. Guan M., Zhou Y., Zhu Q.L., Liu Y., Bei Y.Y., Zhang X.N., Zhang Q. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy. Nanomedicine 2012, 8:1172-1181.
18. Guan R., Ma J., Wu Y., Lu F., Xiao C., Jiang H., Kang T. Development and characterization of lactoferrin nanoliposome: cellular uptake and stability. Nanoscale Res. Lett. 2012, 7:679.
19. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
20. Hansen M.B., Nielsen S.E., Berg K. Re-examination and and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989, 119:203-210.
21. Hong C.Y., Yamauchi Y., Wu K.C.W. In vitro cytotoxic-Ity and intracellular bioimaging of dendritic platinum nanoparticles by differential interference contrast. Chem. Lett. 2011, 40:408.
22. Huang S.L. Liposomes in ultrasonic drug and gene delivery. Adv. Drug Deliv. Rev. 2008, 60:1167-1176.
23. Kruzel M.L., Actor J.K., Radak Z., Bacsi A., Saavedra-Molina A., Boldogh I. Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immun. 2010, 16:67-79.
24. Li D., Sakashita S., Morishita Y., Kano J., Shiba A., Sato T., Noguchi M. Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line. Anticancer Res. 2011, 31:529-534.
25. Moradi I., Behjati M., Kazemi M. Application of anodized titanium for enhanced recruitment of endothelial progenitor cells. Nanoscale Res. Lett. 2012, 7:298.
26. Mozafari M.R., Johnson C., Hatziantoniou S., Demetzos C. Nanoliposomes and their applications in food nanotechnology. J. Liposome Res. 2008, 18:309-327.
27. Park Y.G., Jeong J.K., Lee J.H., Lee Y.J., Seol J.W., Kim S.J., Hur T.Y., Jung Y.H., Kang S.J., Park S.Y. Lactoferrin protects against prion protein-induced cell death in neuronal cells by preventing mitochondrial dysfunction. Int. J. Mol. Med. 2013, 31:325-330.
28. Pierce A., Legrand D., Mazurier J. Lactoferrin: a multifunctional protein. Med. Sci. (Paris) 2009, 25:361-369.
29. Ruozi B., Tosi G., Forni F., Fresta M., Vandelli M.A. Atomic force microscopy and photon correlation spectroscopy: two techniques for rapid characterization of liposomes. Eur. J. Pharm. Sci. 2005, 25:81-89.
30. Serikawa T., Suzuki N., Kikuchi H., Tanaka K., Kitagawa T. A new cationic liposome for efficient gene delivery with serum into cultured human cells: a quantitative analysis using two independent fluorescent probes. Biochim. Biophys. Acta 2000, 1467:419-430.
31. Szoka F., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 1978, 75:4194-4198.
32. Tang S., Gao D., Zhao T., Zhou J., Zhao X. An evaluation of the anti-tumor efficacy of oleanolic acid-loaded PEGylated liposomes. Nanotechnology 2013, 24:235102.
33. Tiwari B.K., Valdramidis V.P., O'Donnell C.P., Muthukumarappan K., Bourke P., Cullen P.J. Application of natural antimicrobials for food preservation. J. Agric. Food Chem. 2009, 57:5987-6000.
34. Wakabayashi H., Yamauchi K., Takase M. Lactoferrin research, technology and applications. Int. Dairy J. 2006, 16:1241-1251.
35. Wang X. Preparation of lactoferrin liposomes. Food Nutr. China 2008, 8:40-43.
36. Wang W.P., Iigo M., Sato J., Sekine K., Adachi I., Tsuda H. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res. 2000, 91:1022-1027.
37. Wang R., Tian Z., Chen L. Nano-encapsulations liberated from barley protein microparticles for oral delivery of bioactive compounds. Int. J. Pharm. 2011, 406:153-162.
38. Weng G.Y., Chen M.F. Effect of the oxidative product of lecithin in liposomes on hemolysis. Acta Biochim. Biophys. Sin. 1990, 17:76-77.
39. Xia S., Xu S., Zhang X. Optimization in the preparation of coenzyme Q10 nanoliposomes. J. Agric. Food Chem. 2006, 54:6358-6366.
40. Zhang L.J., Xing B., Wu J., Xu B., Fang X.L. Biodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes. Pulm. Pharmacol. Ther. 2008, 21:239-246.